SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Alpha and beta proteins (a/b) (23833)
(-)
Fold: Flavodoxin-like (1057)
(-)
Superfamily: Flavoproteins (208)
(-)
Family: Quinone reductase (65)
(-)
Protein domain: ACP phosphodiesterase AcpD (8)
(-)
Escherichia coli [TaxId: 562] (7)
1TIKA:CRYSTAL STRUCTURE OF ACYL CARRIER PROTEIN PHOSPHODIESTERASE
1V4BA:THE CRYSTAL STRUCTURE OF AZOR (AZO REDUCTASE) FROM ESCHERICHIA COLI: OXIDIZED FORM
2D5IA:THE CRYSTAL STRUCTURE OF AZOR (AZO REDUCTASE) FROM ESCHERICHIA COLI
2Z98A:THE CRYSTAL STRUCTURE OF AZOR (AZOREDUCTASE) FROM ESCHERICHIA COLI: OXIDIZED AZOR IN TETRAGONAL CRYSTALS (THE RESOLUTION HAS IMPROVED FROM 1.8 (1V4B) TO 1.4 ANGSTROM)
2Z9BA:THE CRYSTAL STRUCTURE OF AZOR (AZOREDUCTASE) FROM ESCHERICHIA COLI: REDUCED AZOR IN TETRAGONAL CRYSTALS
2Z9CA:THE CRYSTAL STRUCTURE OF AZOR (AZOREDUCTASE) FROM ESCHERICHIA COLI: AZOR IN COMPLEX WITH DICOUMAROL
2Z9DA:; B:THE CRYSTAL STRUCTURE OF AZOR (AZOREDUCTASE) FROM ESCHERICHIA COLI: OXIDIZED AZOR IN ORTHORHOMBIC CRYSTALS
(-)
Salmonella typhimurium [TaxId: 90371] (1)
1T5BA:; B:STRUCTURAL GENOMICS, A PROTEIN FROM SALMONELLA TYPHIMURIUM SIMILAR TO E. COLI ACYL CARRIER PROTEIN PHOSPHODIESTERASE
(-)
Protein domain: automated matches (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
2BZSA:; B:BINDING OF ANTI-CANCER PRODRUG CB1954 TO THE ACTIVATING ENZYME NQO2 REVEALED BY THE CRYSTAL STRUCTURE OF THEIR COMPLEX.
2F1OA:; B:; C:; D:; E:; F:; G:; H:CRYSTAL STRUCTURE OF NQO1 WITH DICOUMAROL
(-)
Yersinia pestis [TaxId: 214092] (1)
4ESEA:THE CRYSTAL STRUCTURE OF AZOREDUCTASE FROM YERSINIA PESTIS CO92 IN COMPLEX WITH FMN.
(-)
Protein domain: NAD(P)H:quinone reductase (10)
(-)
Human (Homo sapiens) [TaxId: 9606] (8)
1D4AA:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE AT 1.7 A RESOLUTION
1DXOA:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,3, 5,6,TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2.5 ANGSTROM RESOLUTION
1GG5A:; B:; C:; D:CRYSTAL STRUCTURE OF A COMPLEX OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE AND A CHEMOTHERAPEUTIC DRUG (E09) AT 2.5 A RESOLUTION
1H66A:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,5-DIAZIRIDINYL-3-HYDROXYL-6-METHYL-1,4-BENZOQUINONE
1H69A:; C:; D:; B:CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,3,5,6,TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2.5 ANGSTROM RESOLUTION
1KBOA:; B:; C:; D:COMPLEX OF HUMAN RECOMBINANT NAD(P)H:QUINONE OXIDE REDUCTASE TYPE 1 WITH 5-METHOXY-1,2-DIMETHYL-3-(PHENOXYMETHYL)INDOLE-4,7-DIONE (ES1340)
1KBQA:; B:; C:; D:COMPLEX OF HUMAN NAD(P)H QUINONE OXIDOREDUCTASE WITH 5-METHOXY-1,2-DIMETHYL-3-(4-NITROPHENOXYMETHYL)INDOLE-4,7-DIONE (ES936)
1QBGA:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN DT-DIAPHORASE (NAD(P)H OXIDOREDUCTASE)
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1DXQA:; B:; C:; D:CRYSTAL STRUCTURE OF MOUSE NAD[P]H-QUINONE OXIDOREDUCTASE
(-)
Rat (Rattus rattus) [TaxId: 10117] (1)
1QRDA:; B:QUINONE REDUCTASE/FAD/CIBACRON BLUE/DUROQUINONE COMPLEX
(-)
Protein domain: Quinone reductase type 2 (menadione reductase) (44)
(-)
Human (Homo sapiens) [TaxId: 9606] (44)
1QR2A:; B:HUMAN QUINONE REDUCTASE TYPE 2
1SG0A:; B:CRYSTAL STRUCTURE ANALYSIS OF QR2 IN COMPLEX WITH RESVERATROL
1XI2A:; B:QUINONE REDUCTASE 2 IN COMPLEX WITH CANCER PRODRUG CB1954
1ZX1A:; B:HUMAN QUINONE OXIDOREDUCTASE 2 (NQO2) IN COMPLEX WITH THE CYTOSTATIC PRODRUG CB1954
2QMYA:; B:QUINONE REDUCTASE 2 IN COMPLEX WITH ADRENOCHROME
2QMZA:; B:QUINONE REDUCTASE 2 IN COMPLEX WITH DOPAMINE
2QR2A:; B:HUMAN QUINONE REDUCTASE TYPE 2, COMPLEX WITH MENADIONE
2QWXA:; B:CRYSTAL STRUCTURE OF QUINONE REDUCTASE II
2QX4A:; B:CRYSTAL STRUCTURE OF QUINONE REDUCTASE II
2QX6A:; B:CRYSTAL STRUCTURE OF QUINONE REDUCTASE II
2QX8A:; B:CRYSTAL STRUCTURE OF QUINONE REDUCTASE II
2QX9A:; B:CRYSTAL STRUCTURE OF QUINONE REDUCTASE II
3FW1A:QUINONE REDUCTASE 2
3G5MA:; B:SYNTHESIS OF CASIMIROIN AND OPTIMIZATION OF ITS QUINONE REDUCTASE 2 AND AROMATASE INHIBITORY ACTIVITY
3GAMA:; B:SYNTHESIS OF CASIMIROIN AND OPTIMIZATION OF ITS QUINONE REDUCTASE 2 AND AROMATASE INHIBITORY ACTIVITY
3NFRA:; B:CASIMIROIN ANALOG INHIBITOR OF QUINONE REDUCTASE 2
3NHFA:; B:X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2
3NHJA:; B:X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2
3NHKA:; B:X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2
3NHLA:; B:X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2
3NHPA:; B:X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2
3NHRA:; B:X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2
3NHSA:; B:X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2
3NHUA:; B:X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2
3NHWA:; B:X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2
3NHYA:; B:X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2
3O2NA:; B:X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2
3O73A:; B:CRYSTAL STRUCTURE OF QUINONE REDUCTASE 2 IN COMPLEX WITH THE INDOLEQUINONE MAC627
3OVMA:; B:X-RAY STRUCTURAL STUDY OF QUINONE REDUCTASE II INHIBITION BY COMPOUNDS WITH MICROMOLAR TO NANOMOLAR RANGE IC50 VALUES
3OWHA:; B:X-RAY STRUCTURAL STUDY OF QUINONE REDUCTASE II INHIBITION BY COMPOUNDS WITH MICROMOLAR TO NANOMOLAR RANGE IC50 VALUES
3OWXA:; B:X-RAY STRUCTURAL STUDY OF QUINONE REDUCTASE II INHIBITION BY COMPOUNDS WITH MICROMOLAR TO NANOMOLAR RANGE IC50 VALUES
3OX1A:; B:X-RAY STRUCTURAL STUDY OF QUINONE REDUCTASE II INHIBITION BY COMPOUNDS WITH MICROMOLAR TO NANOMOLAR RANGE IC50 VALUES
3OX2A:; B:X-RAY STRUCTURAL STUDY OF QUINONE REDUCTASE II INHIBITION BY COMPOUNDS WITH MICROMOLAR TO NANOMOLAR RANGE IC50 VALUES
3OX3A:; B:X-RAY STRUCTURAL STUDY OF QUINONE REDUCTASE II INHIBITION BY COMPOUNDS WITH MICROMOLAR TO NANOMOLAR RANGE IC50 VALUES
3TE7A:; B:QUINONE OXIDOREDUCTASE (NQ02) BOUND TO THE IMIDAZOACRIDIN-6-ONE 5A1
3TEMA:; B:QUINONE OXIDOREDUCTASE (NQ02) BOUND TO THE IMIDAZOACRIDIN-6-ONE 6A1
3TZBA:; B:; C:; D:QUINONE OXIDOREDUCTASE (NQ02) BOUND TO NSC13000
3UXEA:; B:DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF POTENT QUINOLINE AND PYRROLOQUINOLINE AMMOSAMIDE ANALOGUES AS INHIBITORS FOR QUINONE REDUCTASE 2
3UXHA:; B:DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF POTETENT QUINOLINE AND PYRROLOQUINOLINE AMMOSAMIDE ANALOGUES AS INHIBITORS OF QUINONE REDUCTASE 2
4FGJA:; B:OXIDIZED QUINONE REDUCTASE 2 IN COMPLEX WITH PRIMAQUINE
4FGKA:; B:OXIDIZED QUINONE REDUCTASE 2 IN COMPLEX WITH CHLOROQUINE
4FGLA:; B:; C:; D:REDUCED QUINONE REDUCTASE 2 IN COMPLEX WITH CHLOROQUINE
4GQIA:; B:SYNTHESIS OF NOVEL MT3 RECEPTOR LIGANDS VIA UNUSUAL KNOEVENAGEL CONDENSATION
4GR9A:; B:SYNTHESIS OF NOVEL MT3 RECEPTOR LIGANDS VIA UNUSUAL KNOEVENAGEL CONDENSATION